Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 52

The DOI matches its Crossref record.

BRCA1 and BRCA2 Genetic Testing in Hispanic Patients: Mutation Prevalence and Evaluation of the BRCAPRO Risk Assessment Model

Vogel, Kristen J., Atchley, Deann P., Erlichman, Julie, Broglio, Kristine R., Ready, Kaylene J., Valero, Vicente, Amos, Christopher I., Hortobagyi, Gabriel N., Lu, Karen H., Arun, Banu · 2007 · Journal of Clinical Oncology

Abstract

Purpose: The BRCAPRO model, used to predict a family's likelihood of carrying a BRCA1 or BRCA2 mutation, was designed using mutation frequencies of white and Ashkenazi Jewish populations, and may not be applicable to other populations. BRCAPRO was recently validated in African Americans, although has yet to be examined in Hispanics. This retrospective study reports the mutation frequency and spectrum of BRCA1 and BRCA2 mutations in a Hispanic population and evaluates the BRCAPRO model in Hispanics. Patients and Methods: A descriptive analysis of mutation frequency and spectrum was performed for Hispanic patients who underwent BRCA1 and BRCA2 genetic testing at a single institution. For comparative analysis of the BRCAPRO risk model, Hispanic patients who underwent comprehensive analysis were compared with white controls using area under the receiver operating characteristic curves (AUROC). Results: Fourteen Hispanic individuals who underwent comprehensive analysis were identified to carry a mutation in BRCA1 or BRCA2 (17.9%; 95% CI, 10.2% to 28.3%) and seven individuals had a variant of uncertain significance (9.0%; 95% CI, 12.0% to 30.8%). A total of eight different mutations and three variants were observed within the entire Hispanic population. When evaluating the performance of the BRCAPRO model, the AUROC for Hispanics was 0.774 (95% CI, 0.63 to 0.90), compared with the AUROC of 0.770 (95% CI, 0.65 to 0.89) for whites. Conclusion: Deleterious BRCA1 and BRCA2 mutations occur at considerable frequency within the Hispanic population, many of which have been identified previously in other ethnic populations. The BRCAPRO model appears to perform equally well in Hispanics as in whites.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2006.10.4703

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 40

  1. 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z · DOI · Paper page
  2. 10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P · doi:10.1002/(sici)1097-0142(20000315)88:6<1393::aid-cncr17>3.0.co;2-p
  3. 10.1002/cncr.21536 · DOI · Paper page
  4. 10.1093/jnci/91.11.943 · DOI · Paper page
  5. 10.1086/318787 · DOI · Paper page
  6. 10.1086/301749 · DOI · Paper page
  7. 10.1200/JCO.2005.03.6772 · DOI · Paper page
  8. 10.1126/science.1088759 · DOI · Paper page
  9. 10.1002/humu.10260 · DOI · Paper page
  10. 10.1200/JCO.2002.20.6.1480 · DOI · Paper page
  11. 10.1001/jama.294.15.1925 · DOI · Paper page
  12. 10.1001/jama.1997.03550150046034 · DOI · Paper page
  13. 10.1038/sj.ejhg.5200717 · DOI
  14. Baudi F, Quaresima B, Grandinetti C, et al: Evidence of a founder mutation of in a highly homogeneous population from southern Italy with breast/ovarian cancer. Hum Mutat 18:163,2001-164, BRCA1 · DOI
  15. 10.1002/ijc.1627 · DOI
  16. 10.1007/s004390050895 · doi:10.1007/s004390050895
  17. 10.1002/humu.10154 · DOI
  18. 10.1186/bcr1282 · DOI
  19. Ruiz-Flores P, Sinilnikova OM, Badzioch M, et al: and mutation analysis of early-onset and familial breast cancer cases in Mexico. Hum Mutat 20:474,2002-475, BRCA1 BRCA2 · doi:10.1002/humu.9084
  20. Sarantaus L, Auranen A, Nevanlinna H: and mutations among Finnish ovarian carcinoma families. Int J Oncol 18:831,2001-835, BRCA1 BRCA2 · doi:10.3892/ijo.18.4.831
  21. Sng JH, Ali AB, Lee SC, et al: c. 2845insA is a founder mutation in Singaporean Malay women with early onset breast/ovarian cancer. Ann Acad Med Singapore 32:S53,2003-S55, BRCA1 · DOI
  22. Armstrong K, Weber B, Stopfer J, et al: Early use of clinical testing: Associations with race and breast cancer risk. Am J Med Genet A 117:154,2003-160, BRCA1/2 · DOI
  23. 10.1001/jama.293.14.1729 · DOI · Paper page
  24. 10.1007/s00439-004-1240-5 · DOI
  25. 10.1002/cncr.11533 · DOI
  26. 10.1158/1055-9965.EPI-05-0072 · doi:10.1158/1055-9965.epi-05-0072
  27. 10.1200/JCO.2005.02.2368 · DOI
  28. 10.1200/JCO.2002.05.121 · DOI · Paper page
  29. 10.1086/301670 · DOI · Paper page
  30. 10.1093/bioinformatics/bti623 · DOI · Paper page
  31. Blesa JR, Garcia JA, Ochoa E: Frequency of germ-line mutations among Spanish families from a Mediterranean area. Hum Mutat 15:381,2000-382, BRCA1 · doi:10.1002/(sici)1098-1004(200004)15:4<381::aid-humu14>3.0.co;2-h
  32. Osorio A, Robledo M, Martinez B, et al: Molecular analysis of the gene in 16 breast/ovarian cancer Spanish families. Clin Genet 54:142,1998-147, BRCA2 · doi:10.1111/j.1399-0004.1998.tb03717.x
  33. 10.1038/ng1095-198 · DOI · Paper page
  34. 10.1093/jnci/89.3.227 · DOI · Paper page
  35. 10.1046/j.1524-4741.2001.20012.x · DOI
  36. 10.1200/JCO.2006.05.5889 · DOI · Paper page
  37. 10.1093/jnci/94.11.844 · DOI
  38. 10.1002/cncr.11434 · doi:10.1002/cncr.11434
  39. Parmigiani G, Chen S, Iversen E, et al: Validity of models for prediction of and mutations. Ann Intern Med (in press)BRCA1 BRCA2
  40. 10.1093/jnci/93.11.824 · DOI · Paper page

Cited by

See all 52

Metadata

Authors
Vogel, K. J., Atchley, D. P., Erlichman, J., Broglio, K. R., Ready, K. J., Valero, V., Amos, C. I., Hortobagyi, G. N., Lu, K. H., & Arun, B.
Venue
Journal of Clinical Oncology
Published
2007-10-10
Volume
25
Issue
29
Pages
4635-4641
ISSN
  • 0732-183X
  • 1527-7755
Cited by
52
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BRCA1 and BRCA2 Genetic Testing in Hispanic Patients: Mutation Prevalence and Evaluation of the BRCAPRO Risk Assessment Model. https://app.cochat.ai/papers/10.1200/jco.2006.10.4703
The paper
Vogel, K. J., Atchley, D. P., Erlichman, J., Broglio, K. R., Ready, K. J., Valero, V., Amos, C. I., Hortobagyi, G. N., Lu, K. H., & Arun, B. (2007). BRCA1 and BRCA2 Genetic Testing in Hispanic Patients: Mutation Prevalence and Evaluation of the BRCAPRO Risk Assessment Model. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2006.10.4703

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.